Why Statins Matter Around Surgery
- Statins (HMG-CoA reductase inhibitors) lower LDL cholesterol by blocking an enzyme in the liver responsible for cholesterol synthesis. They are prescribed for patients with high cholesterol, coronary artery disease, prior heart attack or stroke, and for primary prevention in patients with significant cardiovascular risk factors.
- Beyond lowering cholesterol, statins have anti-inflammatory and plaque-stabilizing effects that are particularly relevant in the surgical setting. Surgical stress triggers inflammation that can destabilize atherosclerotic plaques in coronary arteries. Statins help maintain plaque stability during this period.
- Clinical evidence supports continuing statins through cardiac and major vascular surgery. Studies show that statin use around the time of cardiac surgery is associated with lower rates of atrial fibrillation, reduced mortality, and shorter hospital stays.
- Abruptly stopping statins before surgery can cause a rebound inflammatory effect. In patients with established coronary artery disease, statin discontinuation has been associated with increased risk of cardiovascular events in the peri-operative period. For this reason, most guidelines recommend continuing statins without interruption.
Common Statins and Their Characteristics
- Atorvastatin (Lipitor) is one of the most widely prescribed statins and one of the most potent. It is taken once daily and can be taken at any time of day. It lowers LDL by up to 50 percent at maximum doses. Atorvastatin has a longer half-life than many other statins, which means a missed dose has less impact on blood levels.
- Rosuvastatin (Crestor) is the most potent available statin at equivalent doses. It is taken once daily and is water-soluble, which gives it a different metabolism profile and fewer drug interactions than fat-soluble statins. It is often preferred in patients on many concurrent medications.
- Simvastatin (Zocor) is a fat-soluble statin taken in the evening (cholesterol synthesis is highest overnight). It has significant drug interactions with certain antibiotics, antifungals, and calcium channel blockers. Patients on simvastatin should check for interactions when any new medication is added.
- Pravastatin and fluvastatin are lower-potency statins with fewer drug interactions, sometimes preferred in transplant patients or in patients on complex medication regimens.
- High-intensity statin therapy (atorvastatin 40 to 80 mg or rosuvastatin 20 to 40 mg) is the standard of care for patients with established atherosclerotic cardiovascular disease. Moderate-intensity therapy is used for primary prevention. Do not change your dose without provider guidance.
Taking Statins Correctly During Recovery
- Continue your statin through surgery unless your surgeon or anesthesiologist specifically instructs otherwise. Most surgical guidelines recommend uninterrupted statin use. If you are unable to take oral medications after surgery, ask your care team about when you should restart.
- Atorvastatin and rosuvastatin can be taken at any time of day. Simvastatin should be taken in the evening. Taking statins at a consistent time each day improves adherence.
- Statins have no significant food interactions for most patients. Grapefruit and grapefruit juice, however, inhibit the liver enzyme CYP3A4 that metabolizes atorvastatin, simvastatin, and lovastatin. Large quantities of grapefruit can increase statin blood levels and raise the risk of muscle side effects. Rosuvastatin and pravastatin are not affected by grapefruit.
- Alert your provider to every new medication added during recovery, including antibiotics. Certain antibiotics, particularly azithromycin, clarithromycin, and antifungals like fluconazole, inhibit the same liver enzymes that process fat-soluble statins. This can temporarily increase statin levels and muscle side effect risk.
- If you are placed on a statin for the first time around the time of surgery, report any new muscle symptoms within the first 4 to 8 weeks. This is the highest-risk period for detecting statin-related muscle problems.
Side Effects and Interactions to Watch For
- Muscle-related side effects are the most clinically important adverse effects of statins. Myalgia (muscle aches) occurs in roughly 5 to 10 percent of patients. It typically presents as diffuse muscle aching, heaviness, or weakness, often in the thighs and shoulders. Symptoms usually improve within weeks of stopping or changing the statin.
- Rhabdomyolysis is a rare but serious breakdown of muscle tissue that releases proteins into the bloodstream, which can damage the kidneys. Symptoms include severe muscle pain and weakness, dark or tea-colored urine, and markedly decreased urine output. This is a medical emergency. Seek immediate care if these symptoms develop.
- Post-surgical muscle soreness from immobility, pain, or the surgical site itself can be difficult to distinguish from statin-related myalgia. A helpful clue: statin myalgia tends to be diffuse and symmetrical, while surgical muscle soreness is typically localized near the incision or operative site. Discuss any new widespread muscle symptoms with your provider.
- Liver enzyme elevations occur in a small percentage of patients on statins. Significant liver toxicity is rare. Symptoms of liver problems include yellowing of the skin or eyes, dark urine, and unexplained right-sided abdominal discomfort. These warrant immediate provider contact.
- Statin interactions to watch for during recovery: azithromycin and clarithromycin with atorvastatin or simvastatin (increased muscle risk), fluconazole with simvastatin (significant interaction, dose adjustment may be needed), and niacin with any statin (increased myopathy risk).